Synergistic effects of ethosomes and chemical enhancers on enhancement of naloxone permeation through human skin

Pharmazie

Volumn 62, Issue 4, 2007, Pages 316-318

  Xu, D H ^a   Zhang, Q ^a   Feng, X ^a   Xu, Xiang ^a   Liang, W Q ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; DRUG CARRIER; ETHOSOME DERIVATIVE; LAUROCAPRAM; MACROGOL 400; N,N DIMETHYLACETAMIDE; N,N DIMETHYLFORMAMIDE; NALOXONE; PROPYLENE GLYCOL; UNCLASSIFIED DRUG;

ARTICLE; DRUG PENETRATION; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG SYNERGISM; EXCIPIENTS; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; SKIN ABSORPTION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 34247155737     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.4.6225     Document Type: Article

References (12)

1. Aungst BJ, Rogers NJ, Shefter E (1986) Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm 33: 225-234.
2. Dayan N, Touitou E (2000) Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21: 1879-1885.
3. Godin B, Touitou E (2003) Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst 20: 63-102.
4. Godin B, Touitou E (2004) Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J Control Release 94: 365-379.
5. Honeywell-Nguyen PL, de Graaff AM, Groenink HW, Bouwstra JA (2002) The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim Biophys Acta 1573: 130-140.
6. Jaiswal J, Poduri R, Panchagnula R (1999) Transdermal delivery of naloxone: ex vivo permeation studies. Int J Pharm 179: 129-134.
7. Lodzki M, Godin B, Rakou L, Mechoulam R, Gallily R, Touitou E (2003) Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. J Control Release 93: 377-387.
8. Ngai SH, Berkowitz BA, Yang JC, Hempstead J, Spector S (1976) Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action. Anesthesiology 44: 398-401.
9. Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P (2001) Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm. 219: 95-105.
10. Panchagnula R, Sharma P, Khandavilli S, Varma MV (2004) RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulation. Farmaco 59: 839-842.
11. Panchagnula R, Bokalial R, Sharma P, Khandavilli S (2005) Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Int J Pharm 293: 213-223.
12. Touiton E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ehosome-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65: 403-418.